PulseAugur
EN
LIVE 09:12:46
ENTITY Boshengji Medicine

Boshengji Medicine

PulseAugur coverage of Boshengji Medicine — every cluster mentioning Boshengji Medicine across labs, papers, and developer communities, ranked by signal.

Show in brief
Total · 30d
1
1 over 90d
Releases · 30d
0
0 over 90d
Papers · 30d
1
1 over 90d
TIER MIX · 90D
TOPICS
TIMELINE
  1. 2026-06-06 research_milestone Boshengji Medicine initiated a Phase 1 clinical trial for its CD7 CAR-T therapy in pediatric patients. source
SENTIMENT · 30D

1 day(s) with sentiment data

RECENT · PAGE 1/1 · 1 TOTAL
  1. TOOL · CL_74515 ·

    Anke Bio subsidiary launches world's first CD7 CAR-T pediatric trial

    Anke Bio's subsidiary, Boshengji Medicine, has initiated a Phase 1 clinical trial for its CD7 CAR-T therapy in pediatric patients with relapsed/refractory T-lymphoblastic leukemia/lymphoma. This marks a significant adva…